{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T14:09:44Z","timestamp":1788790184254,"version":"build-2803163510"},"reference-count":96,"publisher":"Informa UK Limited","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Postgraduate Medicine"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.3810\/pgm.2012.11.2616","type":"journal-article","created":{"date-parts":[[2013,1,4]],"date-time":"2013-01-04T11:13:01Z","timestamp":1357297981000},"page":"98-109","source":"Crossref","is-referenced-by-count":37,"title":["Hyperuricemia and Gout: New Concepts in Diagnosis and Management"],"prefix":"10.1080","volume":"124","author":[{"given":"Paul P.","family":"Doghramji","sequence":"first","affiliation":[{"name":"Medical Director of Health Services, Collegeville Family Practice, Ursinus College, Collegeville, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Wortmann","sequence":"additional","affiliation":[{"name":"Section of Rheumatology, Dartmouth Medical School, Lebanon, NH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,3,13]]},"reference":[{"key":"e_1_2_1_2_1","unstructured":". Perez\u2014Ruiz F Herrero\u2014Beites AM. Evaluation and treatment of gout as a chronic disease [published online ahead of print October 25 2012]. Adv Ther."},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.3949\/ccjm.75.Suppl_5.S2","article-title":"The pathogenesis of gout","volume":"75","author":"Schumacher HR","year":"2008","unstructured":". Schumacher HR Jr. The pathogenesis of gout. Cleve Clin J Med. 2008;75(suppl 5):S2\u2013S4","journal-title":"Cleve Clin J Med."},{"issue":"2","key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11926-010-0084-3","article-title":"Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect?","volume":"12","author":"Shah A","year":"2010","unstructured":". Shah A, Keenan RT. Gout, hyperuricemia, and the risk of cardiovascular disease: cause and effect? Curr Rheumatol Rep. 2010;12(2):118\u2013124","journal-title":"Curr Rheumatol Rep."},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2011.11.2511"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30520"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27425"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar1907"},{"key":"e_1_2_1_9_1","first-page":"1481","volume-title":"Kelley 's Textbook of Rheumatology.","author":"Wortmann RL","year":"2008","unstructured":". Wortmann RL. Gout and hyperuricemia. In: Firestein GS, Budd RC, Harris ED Jr, , eds. Kelley 's Textbook of Rheumatology. 8th ed. Volume I. Philadelphia, PA: W. B. Saunders Company; 2008:1481\u20131506","edition":"8"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.75.Suppl_5.S9"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.168.10.1104"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23176"},{"key":"e_1_2_1_13_1","first-page":"1","article-title":"Current estimates from the National Health Interview Survey, 1996","volume":"200","author":"Adams PF","year":"1999","unstructured":". Adams PF, Hendershot GE, Marano MA; Centers for Disease Control and Prevention\/National Center for Health Statistics. Current estimates from the National Health Interview Survey, 1996. Vital Health Stat 10. 1999;200:1\u2013203","journal-title":"Vital Health Stat 10."},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2011.05.2284"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.3945\/jn.111.151951"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038123"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0b013e3181945d2c"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2011.11.2505"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep047"},{"issue":"1","key":"e_1_2_1_20_1","first-page":"104","article-title":"Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study","volume":"33","author":"Neogi T","year":"2006","unstructured":". Neogi T, Hunter DJ, Chaisson CE, Allensworth\u2014Davies D, Zhang Y. Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study. J Rheumatol. 2006;33(1):104\u2013109","journal-title":"J Rheumatol."},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050373"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-277X.2008.00928.x"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2659"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S6048"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2010.07.001"},{"issue":"3","key":"e_1_2_1_26_1","first-page":"498","article-title":"Gout in ambulatory care settings in the United States","volume":"35","author":"Krishnan E","year":"2008","unstructured":". Krishnan E, Lienesch D, Kwoh CK. Gout in ambulatory care settings in the United States. J Rheumatol. 2008;35(3):498\u2013501","journal-title":"J Rheumatol."},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)60883-7"},{"key":"e_1_2_1_28_1","first-page":"313","volume-title":"Primer on the Rheumatic Diseases.","author":"Edwards NL","year":"2001","unstructured":". Edwards NL. Gout: clinical and laboratory features. In: Klippel JH, Crofford L, Stone JH, , eds. Primer on the Rheumatic Diseases. 12th ed. Atlanta, GA: Arthritis Foundation; 2001:313\u2013319","edition":"12"},{"key":"e_1_2_1_29_1","first-page":"S459","article-title":"Clinical, humanistic, and economic outcomes of gout","volume":"11","author":"Brixner DI","year":"2005","unstructured":". Brixner DI, Ho MJ. Clinical, humanistic, and economic outcomes of gout. Am J Manag Care. 2005;11(15 suppl): S459\u2013S464","journal-title":"Am J Manag Care."},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.33369"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1161\/hy1101.092839"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00283.2001"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3282f240bf"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0b013e328330d9d0"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2008.605"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq363"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0800885"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2005.03.043"},{"issue":"2","key":"e_1_2_1_39_1","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1186\/ar3322","article-title":"Hyperuricemia and the risk for subclinical coronary atherosclerosis\u2014data from a prospective observational cohort study","volume":"13","author":"Krishnan E","year":"2011","unstructured":". Krishnan E, Pandya BJ, Chung L, Dabbous O. Hyperuricemia and the risk for subclinical coronary atherosclerosis\u2014data from a prospective observational cohort study. Arthritis Res Ther. 2011;13(2):R66","journal-title":"Arthritis Res Ther."},{"issue":"4","key":"e_1_2_1_40_1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000239860","article-title":"Serum uric acid for risk stratification of patients with coronary artery disease","volume":"114","author":"Brodov Y","year":"2009","unstructured":". Brodov Y, Chouraqui P, Goldenberg I, Boyko V, Mandelzweig L, Behar S. Serum uric acid for risk stratification of patients with coronary artery disease. Cardiology. 2009;114(4):300\u2013305","journal-title":"Cardiology."},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000254480.64564.b6"},{"key":"e_1_2_1_42_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000085858.66548.59"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22014"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.703389"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24612"},{"issue":"5","key":"e_1_2_1_46_1","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000235731","article-title":"Combination of captopril and allopurinol retards fructose-induced metabolic syndrome","volume":"30","author":"Roncal CA","year":"2009","unstructured":". Roncal CA, Reungjui S, S\u00e1nchez\u2014Lozada LG, . Combination of captopril and allopurinol retards fructose-induced metabolic syndrome. Am J Nephrol. 2009;30(5):399\u2013404","journal-title":"Am J Nephrol."},{"issue":"2","key":"e_1_2_1_47_1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11926-011-0234-2","article-title":"Association between gout and all-cause as well as cardiovascular mortality: a systematic review","volume":"14","author":"Lottmann K","year":"2012","unstructured":". Lottmann K, Chen X, Sch\u00e4dlich PK. Association between gout and all-cause as well as cardiovascular mortality: a systematic review. Curr Rheumatol Rep. 2012;14(2):195\u2013203","journal-title":"Curr Rheumatol Rep."},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.2217\/ijr.11.79"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar1909"},{"issue":"7","key":"e_1_2_1_50_1","first-page":"1799","article-title":"Diagnosis and management of gout","volume":"59","author":"Pittman JR","year":"1999","unstructured":". Pittman JR, Bross MH. Diagnosis and management of gout. Am Fam Physician. 1999;59(7):1799\u20131806, 1810","journal-title":"Am Fam Physician."},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar1908"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29404"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22466"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-010-0098-2"},{"issue":"7","key":"e_1_2_1_55_1","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00004872-199917070-00001","article-title":"Uric acid as a cardiovascular risk factor in arterial hypertension","volume":"17","author":"Puig JG","year":"1999","unstructured":". Puig JG, Ruilope LM. Uric acid as a cardiovascular risk factor in arterial hypertension. J Hypertens. 1999;17(7):869\u2013872","journal-title":"J Hypertens."},{"issue":"9","key":"e_1_2_1_56_1","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s10067-006-0527-4","article-title":"Manifestations of metabolic syndrome associated with male gout in different age strata","volume":"26","author":"Chen SY","year":"2007","unstructured":". Chen SY, Chen CL, Shen ML. Manifestations of metabolic syndrome associated with male gout in different age strata. Clin Rheumatol. 2007;26(9):1453\u20131457","journal-title":"Clin Rheumatol."},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.7.742"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep086"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/87.5.1480"},{"key":"e_1_2_1_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2010.03.027"},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ken305"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1080\/15257771003741273"},{"issue":"5","key":"e_1_2_1_63_1","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.1780080502","article-title":"Treatment of primary gout: the present status","volume":"8","author":"Gutman AB","year":"1965","unstructured":". Gutman AB. Treatment of primary gout: the present status. Arthritis Rheum. 1965;8(5):911\u2013920","journal-title":"Arthritis Rheum."},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.128454"},{"issue":"2","key":"e_1_2_1_65_1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/BOR.0b013e3283257b6c","article-title":"Use of imaging to evaluate gout and other crystal deposition disorders","volume":"21","author":"Dalbeth N","year":"2009","unstructured":". Dalbeth N, McQueen FM. Use of imaging to evaluate gout and other crystal deposition disorders. Curr Opin Rheumatol. 2009;21(2):124\u2013131","journal-title":"Curr Opin Rheumatol."},{"issue":"7","key":"e_1_2_1_66_1","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.3899\/jrheum.110271","article-title":"Patient-reported outcomes in chronic gout: a report from OMERACT 10","volume":"38","author":"Singh JA","year":"2011","unstructured":". Singh JA, Taylor WJ, Simon LS, . Patient-reported outcomes in chronic gout: a report from OMERACT 10. J Rheumatol. 2011;38(7):1452\u20131457","journal-title":"J Rheumatol."},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq346"},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-011-0228-0"},{"key":"e_1_2_1_69_1","doi-asserted-by":"crossref","unstructured":". Langley P Nuki G Forsythe A. Pain health-related quality of life and health status in gout in Europe. Poster presented at: EULAR Annual European Congress of Rheumatology; June 6\u20139 2012; Berlin Germany. Poster FRI0387","DOI":"10.1136\/annrheumdis-2012-eular.2844"},{"key":"e_1_2_1_70_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.055251"},{"key":"e_1_2_1_71_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem058"},{"key":"e_1_2_1_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(87)90441-4"},{"issue":"9","key":"e_1_2_1_73_1","first-page":"1950","article-title":"The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis","volume":"29","author":"Urano W","year":"2002","unstructured":". Urano W, Yamanaka H, Tsutani H, . The inflammatory process in the mechanism of decreased serum uric acid concentrations during acute gouty arthritis. J Rheumatol. 2002;29(9):1950\u20131953","journal-title":"J Rheumatol."},{"issue":"4","key":"e_1_2_1_74_1","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/art.1780270417","article-title":"Tophaceous gout: a clinical and radiographic assessment","volume":"27","author":"Nakayama D","year":"1984","unstructured":". Nakayama D, Barthelemy C, Carrera G, Lightfoot RW Jr, Wortmann RL. Tophaceous gout: a clinical and radiographic assessment. Arthritis Rheum. 1984;27(4):468\u2013471","journal-title":"Arthritis Rheum."},{"issue":"8","key":"e_1_2_1_75_1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jama.1967.03120080059008","article-title":"Diagnostic value of the colchicine therapeutic trial","volume":"199","author":"Wallace SI","year":"1967","unstructured":". Wallace SI, Bernstein D, Diamond H. Diagnostic value of the colchicine therapeutic trial. JAMA. 1967;199(8):525\u2013528","journal-title":"JAMA."},{"key":"e_1_2_1_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27356"},{"key":"e_1_2_1_77_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa035700"},{"key":"e_1_2_1_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20761"},{"key":"e_1_2_1_79_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq256"},{"issue":"9","key":"e_1_2_1_80_1","first-page":"1853","article-title":"Vitamin C intake and serum uric acid concentration in men","volume":"35","author":"Gao X","year":"2008","unstructured":". Gao X, Curhan G, Forman JP, Ascherio A, Choi HK. Vitamin C intake and serum uric acid concentration in men. J Rheumatol. 2008;35(9):1853\u20131858","journal-title":"J Rheumatol."},{"key":"e_1_2_1_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16000-5"},{"key":"e_1_2_1_82_1","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.75.Suppl_5.S22"},{"key":"e_1_2_1_83_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.055269"},{"key":"e_1_2_1_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.27327"},{"key":"e_1_2_1_85_1","volume-title":"Colcrys [package insert]","year":"2012","unstructured":". Colcrys [package insert]. Philadelphia, PA: AR Scientific, Inc; 2012"},{"key":"e_1_2_1_86_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2011.01.008"},{"key":"e_1_2_1_87_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10511"},{"key":"e_1_2_1_88_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.34488"},{"key":"e_1_2_1_89_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar2978"},{"key":"e_1_2_1_90_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24209"},{"key":"e_1_2_1_91_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.1169"},{"key":"e_1_2_1_92_1","volume-title":"Krystexxa [package insert]","year":"2012","unstructured":". Krystexxa [package insert]. East Brunswick, NJ: Savient Pharmaceuticals, Inc; 2012"},{"issue":"3","key":"e_1_2_1_93_1","first-page":"257","article-title":"The year in gout\u20142010\u20132011","volume":"69","author":"Crittenden DB","year":"2011","unstructured":". Crittenden DB, Pillinger MH. The year in gout\u20142010\u20132011. Bul NYU Hosp Jt Dis. 2011;69(3):257\u2013263","journal-title":"Bul NYU Hosp Jt Dis."},{"key":"e_1_2_1_94_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1756-185X.2011.01629.x"},{"key":"e_1_2_1_95_1","unstructured":". Edney A. Regeneron's Arcalyst fails to win US backing for gout. Bloomberg website http:\/\/www.bloomberg.com\/news\/2012-07-31\/regeneron-s-arcalyst-fails-to-win-u-s-backing-for-gout.html. Accessed November 1 2012"},{"key":"e_1_2_1_96_1","unstructured":". Burton TM. FDA panel votes against gout drug. The Wall Street Journal website. http:\/\/online.wsj.com\/article\/SB10001424052702304887904576400062633107174.html. Accessed November 1 2012"},{"key":"e_1_2_1_97_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.33315"}],"container-title":["Postgraduate Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3810\/pgm.2012.11.2616","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T17:17:10Z","timestamp":1770916630000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3810\/pgm.2012.11.2616"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["10.3810\/pgm.2012.11.2616"],"URL":"https:\/\/doi.org\/10.3810\/pgm.2012.11.2616","relation":{},"ISSN":["0032-5481","1941-9260"],"issn-type":[{"value":"0032-5481","type":"print"},{"value":"1941-9260","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}